Recent Story Posts
People and Culture
Preserving Fertility in the Face of a Cancer Diagnosis
Access and Health Equity
Native Health Navigator Program Connects Tribes to Cancer Care
Access and Health Equity
Gilead Helps Put African Nation on Path to Eliminate Hepatitis C
Recent Press Releases
-
June 06, 2024
Gilead Announces New England Journal of Medicine Publication of Data that Demonstrate Bulevirtide with PegIFN Achieved Post-Treatment Undetectable HDV RNA -
June 05, 2024
Gilead’s Seladelpar Demonstrated a Sustained and Consistent Long-Term Efficacy and Safety Profile in Primary Biliary Cholangitis -
June 03, 2024
Kite’s Tecartus® Demonstrates Sustained Overall Survival in Adult Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia -
June 03, 2024
Encouraging New Data Presented on Kite’s Yescarta® for Relapsed/Refractory Central Nervous System Lymphoma
For more information, contact us.
Phone:
1-800-GILEAD-5 (1-800-445-3235)
1-800-GILEAD-5 (1-800-445-3235)